US$ 28.58
injection l-carnitine Injections: A Clinical Guide for Practitioners Compounded Carnitine (L) Injection |
Description
10.1007/bf00788944 Basic Res

In the l-carnitine group, 35.4% (17/48) of patients had hyperammonemia

Given that chronic hepatitis and cirrhosis are major risk factors for HCC, the anti-inflammatory and anti-fibrotic effects of L-carnitine could theoretically contribute to reduced HCC risk in patients with advanced MASLD, but this hypothesis awaits clinical validation

ALCAR is involved in lipid metabolism, where it facilitates the transport of fatty acids into the mitochondria for energy production

Dissolving in 10 ml gives a concentration of 372 mM
